A detailed history of Strategic Wealth Investment Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategic Wealth Investment Group, LLC holds 982 shares of LLY stock, worth $890,389. This represents 0.09% of its overall portfolio holdings.

Number of Shares
982
Previous 2,909 66.24%
Holding current value
$890,389
Previous $1.56 Million 63.38%
% of portfolio
0.09%
Previous 0.28%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

SELL
$525.19 - $619.13 $1.01 Million - $1.19 Million
-1,927 Reduced 66.24%
982 $572,000
Q3 2023

Nov 03, 2023

SELL
$434.7 - $599.3 $17,388 - $23,972
-40 Reduced 1.36%
2,909 $1.56 Million
Q2 2023

Jul 17, 2023

SELL
$350.74 - $468.98 $209,391 - $279,981
-597 Reduced 16.84%
2,949 $1.38 Million
Q1 2023

Apr 24, 2023

SELL
$310.63 - $364.82 $544,223 - $639,164
-1,752 Reduced 33.07%
3,546 $1.22 Million
Q1 2023

Apr 20, 2023

BUY
$310.63 - $364.82 $497,008 - $583,712
1,600 Added 43.27%
5,298 $1.82 Million
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $35,048 - $40,839
109 Added 3.04%
3,698 $0
Q3 2022

Oct 21, 2022

BUY
$296.48 - $337.87 $1.06 Million - $1.21 Million
3,589 New
3,589 $1.16 Million
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $1.17 Million - $1.37 Million
-4,183 Closed
0 $0
Q1 2022

Apr 26, 2022

SELL
$234.69 - $291.66 $30,040 - $37,332
-128 Reduced 2.97%
4,183 $1.2 Million
Q4 2021

Jan 21, 2022

BUY
$224.85 - $279.04 $773,034 - $959,339
3,438 Added 393.81%
4,311 $1.19 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $10,415 - $12,817
-47 Reduced 5.11%
873 $201,000
Q2 2021

Jul 16, 2021

SELL
$180.55 - $233.54 $1.31 Million - $1.7 Million
-7,263 Reduced 88.76%
920 $211,000
Q4 2020

Jan 15, 2021

BUY
$130.46 - $172.63 $1.07 Million - $1.41 Million
8,183 New
8,183 $1.38 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Strategic Wealth Investment Group, LLC Portfolio

Follow Strategic Wealth Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Investment Group, LLC with notifications on news.